Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California Institute for Regenerative Medicine
For Researchers
FUNDING OPPORTUNITIES
Information for Applicants
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
GRANTS
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
CLINICAL RESOURCES
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
RESEARCH RESOURCES
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Leadership
Our History
2023 Annual Report
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report Archive
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Podcast
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
All CIRM Grants
Search Filters »
Disease Focus
(All)
aa Multiple Diseases (Centers & Resoures) (14)
Age-related macular degeneration (13)
Aging (22)
Alpha Thalassemia Major (3)
Alzheimer's Disease (35)
Amyotrophic Lateral Sclerosis (57)
Anemia (10)
Angelman Syndrome (1)
Arthritis (14)
Autism (23)
Autoimmune Disorder (1)
B cell cancers (12)
Beta Thalassemia (5)
Bladder or Urinary Tract Disorder (6)
Blood Cancer (73)
Blood Disorders (114)
Bone Marrow Transplant and Viral Infection (7)
Bone or Cartilage Disease (52)
Brain Cancer (35)
Brain Injury, hypoxic, ischemic (2)
Breast Cancer (9)
Canavan Disease (1)
Cancer (167)
Cartilage defect (4)
Colon Cancer (6)
Corneal Damage (7)
COVID-19 (23)
Cystic Fibrosis (3)
Cystinosis (3)
Danon Disease (4)
Dementia (5)
Developmental Disorders (23)
Diabetes (53)
Diabetic Wounds (2)
Duchenne Muscular Dystrophy (4)
Epidermolysis Bullosa (3)
Epilepsy (12)
Fertility (13)
Genetic Disorder (41)
Hearing Loss (11)
Heart Disease (105)
Heart disease associated with Duchenne muscular dystrophy (2)
Heart failure (12)
Hemophilia A (2)
HIV-related Lymphoma (2)
HIV/AIDS (42)
Huntington's Disease (37)
Hyper IgM Syndrome (2)
Hypertension, pulmonary arterial (2)
Immune Disease (57)
Incontinence (2)
Infectious Disease (55)
Inflammatory bowel disease (1)
Intellectual Disability (5)
Intervertebral disc degeneration (2)
Intestinal Disease (16)
IPEX Syndrome (5)
Kidney Disease (17)
Kidney Failure (14)
Leukemia (10)
Leukemia, Acute Myeloid (AML) (23)
Leukocyte Adhesion Deficiency (2)
Liver Disease (22)
Lung Cancer (6)
Lung Disease, Fibrosis (5)
Lupus, Systemic Lupus Erythematosus (SLE) (2)
Melanoma (13)
Metabolic Disorders (89)
Multiple Myeloma (8)
Multiple Sclerosis (9)
Muscle Injury (3)
Muscular Dystrophy (25)
N/A (441)
Neurological Disorders (309)
Neuropathy (5)
Osteoarthritis (6)
Osteonecrosis (3)
Other (19)
Ovarian Cancer (9)
Pancreatic Cancer (4)
Parkinson's Disease (52)
Pediatrics (74)
Prostate Cancer (7)
Pulmonary Hypertension (4)
Respiratory Disorders (28)
Retinitis Pigmentosa (11)
Rett's Syndrome (7)
Sanfilippo Syndrome/MPS III (2)
Sarcoma (4)
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) (4)
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) (4)
Severe Combined Immunodeficiency, X-linked (X-SCID) (8)
Sickle Cell Disease (23)
Skeletal/Smooth Muscle disorders (45)
Skin cancer (2)
Skin Disease (19)
Solid Tumors (93)
Spina Bifida (5)
Spinal Cord Injury (42)
Spinal Muscular Atrophy (9)
Stroke (29)
Tendon/Ligament/Connective Tissue Injury or Disorder (3)
Thymic Disorder, 22q11 Deletion/DiGeorge (1)
Toxicity (7)
Trauma (11)
Traumatic Brain Injury (5)
Type 1 diabetes (21)
Vascular Disease (17)
Vision Loss (66)
Wounds, ulcers (3)
X-linked Chronic Granulomatous Disease (3)
Zika virus (3)
Institution
(All)
AcuraStem Incorporated (2)
Adjuvant Partners, LLC (1)
Adverum Biotechnologies (1)
Ali Nsair (1)
Alliance Forum Foundation (4)
Allogene Therapeutics (1)
Alto Neuroscience (1)
American Association of Blood Banks (2)
American Institute of Chemical Engineers (AIChE) (1)
Angiocrine Bioscience, Inc. (4)
Ankasa Regenerative Therapeutics, Inc. (2)
Aspen Neuroscience (2)
Aspera Biomedicines, Inc. (1)
Axent Biosciences Inc. (1)
Benjamin D. Yu (1)
Berkeley City College (2)
Biocom Institute (1)
BioEclipse Therapeutics INC. (1)
Biomedical Engineering Society (2)
BioTime, Inc. (1)
Bluebird Bio (1)
Boston Children’s Hospital (1)
Brain Mapping Foundation (2)
Brain Neurotherapy Bio (1)
BrainStorm Cell Therapeutics (1)
BrainXell Therapeutics (2)
Buck Institute for Age Research (9)
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo (4)
Cal Poly Pomona Foundation (1)
Cal State Univ, Fullerton (4)
Cal State Univ, Long Beach (3)
Cal State Univ, Sacramento (3)
Cal State Univ, San Bernadino (4)
Caladrius Biosciences (2)
Calibr (3)
Calidi Biotherapeutics, Inc. (1)
California Institute of Technology (5)
California State University San Marcos Corporation (7)
California State University, Channel Islands (3)
Calimmune, Inc. (1)
Capricor, Inc (2)
Cedars-Sinai Medical Center (45)
Cellerant Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Cellular Dynamics International (1)
Celularity Inc. (1)
Chardan (1)
Charles R. Drew University of Medicine and Science (1)
Children’s Hospital of Los Angeles (18)
Children’s Hospital of Orange County (2)
Children’s Neurobiological Solutions (CNS) Foundation (1)
City College Of San Francisco (3)
City of Hope, Beckman Research Institute (59)
Combangio, Inc. (1)
Cytonus Therapeutics, Inc. (1)
Defined Bioscience, Inc. (1)
Elpida Therapeutics (1)
Escape Therapeutics, Inc (1)
Eureka Therapeutics, Inc. (1)
EVERSANA (1)
ExCellThera Inc. (1)
Excision BioTherapeutics (1)
Fate Therapeutics, Inc. (2)
Fluidigm Corporation (2)
Forty Seven Inc. (2)
FUJIFILM Cellular Dynamics (1)
Gamma Medica-Ideas, Inc. (1)
Genascence Corporation (1)
Geron Corporation (2)
Gladstone Institutes, J. David (39)
Global Genes (1)
GMR Epigenetics (1)
Gordon Research Conferences (3)
Greenstone Biosciences, Inc. (3)
HEALIOS NA, Inc. (1)
Humacyte, Inc. (2)
Human BioMolecular Research Institute (4)
Human Organ Project (1)
Humboldt State University Sponsored Programs Foundation (4)
ImmPACT-Bio, Inc. (1)
Immune-Onc Therapeutics (1)
ImmunoCellular Therapeutics (1)
ImmunoVec (3)
Immusoft Corporation (2)
Int. Soc. for Cell Gene Ther. (1)
Intact Therapeutics, Inc. (1)
International Alliance for Biological Standardization (1)
International Society for Experimental Hematology (1)
International Society for Stem Cell Research (6)
International Symposium on Neural Regeneration, Inc. (1)
iPierian, Inc. (2)
IQVIA, Inc. (2)
Jackson Labs (1)
Jasper Therapeutics, Inc. (1)
jCyte, Inc (2)
JDRF International (2)
Juvena Therapeutics Inc. (1)
Kenai Therapeutics (1)
Keystone Symposia on Molecular and Cellular Biology (3)
La Jolla Institute for Allergy and Immunology (1)
Lineage Cell Therapeutics, Inc. (3)
Loma Linda University (2)
Ludwig Institute for Cancer Research (3)
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center (5)
Luxa Biotechnology (1)
Mahzi Therapeutics (2)
MAX BioPharma, Inc. (1)
Medeor Acquisition Corp. (1)
Midwinter Conference of Immunologists (3)
Minutia, Inc. (2)
MiraCosta College (1)
Mohammad Pashmforoush (1)
Mosaic Event Management, Inc. (1)
MyoGene Bio LLC (1)
Nammi Therapeutics, Inc. (1)
Nanotools Bioscience (1)
Navega Therapeutics (1)
Neurona Therapeutics (5)
Nexcella, Inc. (1)
Nohla Therapeutics Inc (1)
Novoglia, Inc. (2)
Numerate, Inc. (1)
OCTANe Foundation for Innovation (1)
Ocular Research Symposia Foundation, Inc. (1)
OncoMed Pharmaceuticals, Inc. (1)
Orchard Therapeutics plc (1)
Organos, Inc. (1)
Ossium Health, Inc. (1)
Palo Alto Veterans Institute for Research (6)
Parkinson’s Institute (5)
Pasadena City College (3)
Pathways to Stem Cell Science (1)
Poseida Therapeutics, Inc. (2)
Rampart Bioscience (1)
RARE-X (1)
Ray Therapeutics, INC (2)
Regencor, Inc. (1)
Regenerative Patch Technologies LLC (1)
Rejuvenate Bio (1)
Rejuvenation Technologies, Inc. (1)
Replay Holdings, Inc (1)
Research for Cure (1)
Reza Ardehali (1)
Rocket Pharmaceuticals, Inc. (3)
Rubedo Life Sciences Inc. (1)
Rumi Scientific CA (1)
RUNX1 Research Program (1)
Salk Institute for Biological Studies (25)
Samumed, LLC (1)
San Diego State University Foundation (5)
San Francisco State University (4)
SanBio, Inc. (1)
Sanford Burnham Prebys Medical Discovery Institute (28)
Sanford Consortium for Regenerative Medicine (8)
Sangamo BioSciences, Inc. (2)
Scaled Biolabs Inc. (1)
Scripps Health (5)
Scripps Research Institute (31)
Semma Therapeutics (1)
Senti Biosciences, Inc. (1)
Siren Biotechnology, Inc. (1)
SJSU Research Foundation (3)
Solano Community College (1)
St. Jude Children’s Research Hospital (1)
Stanford University (179)
StemCells, Inc. (3)
Summit for Stem Cell Foundation (1)
SynGAP Research Fund (1)
Tachyon Therapeutics, Inc (1)
Tenaya Therapeutics, Inc. (1)
The American Society of Gene & Cell Therapy (1)
The Biomedical Engineering Society (1)
The Regents of the University of California on behalf of its Riverside Campus (11)
The Scintillon Institute (2)
The Stone Research Foundation for Sports Medicine and Arthritis (1)
The University Corporation at California State University, Northridge (4)
Tippi C. Mackenzie (1)
Tr1X Inc. (1)
TriFoil Imaging, Inc. (1)
UCSF Benioff Children’s Hospital Oakland (8)
University of California, Berkeley (34)
University of California, Davis (77)
University of California, Irvine (72)
University of California, Los Angeles (163)
University of California, Merced (8)
University of California, San Diego (139)
University of California, San Francisco (125)
University of California, Santa Barbara (14)
University of California, Santa Cruz (16)
University of Southern California (53)
Vala Sciences, Inc. (1)
Vertuis Bio, Inc. (1)
ViaCyte, Inc. (9)
VistaGen Therapeutics, Inc. (1)
Vitabolus, Inc. (1)
Vitalant Research Institute (6)
VxBiosciences inc. (1)
Wake Forest University Health Sciences (1)
Western University of Health Sciences (1)
X-Therma Inc. (1)
Zenobia Therapeutics (1)
Program Type
(All)
Clinical (172)
Discovery (723)
Education (326)
Infrastructure (104)
Translation (156)
Grant Type
(All)
Accelerated Development Pathway I (1)
Accelerating Center (1)
Alpha Stem Cell Clinics (3)
Alpha Stem Cell Clinics Network Expansion (12)
Basic Biology I (12)
Basic Biology II (16)
Basic Biology III (27)
Basic Biology IV (28)
Basic Biology V (28)
Bridges (16)
Bridges (29)
Clinical Trial Stage Projects (3)
Clinical Trial Stage Projects (92)
COMPASS Training Grant (16)
Comprehensive Grant (29)
Conference (81)
Conference – 2024 CIRM Trainee Network Conference (1)
Conference – Lung Regenerative Medicine Workshop (1)
Conference – Manage a Symposium on Pluripotent Stem Cell Manufacturing (1)
Conference – Manage The 2016 Bridges And SPARK Annual Meetings (1)
Conference – Manage The Bridges Annual Meeting (4)
Conference – Manage The SPARK Annual Meeting (7)
Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2017 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2018 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The Alpha Stem Cell Clinic Annual Symposium (2)
Conference – The 2020 Grantee Meeting (1)
Conference II (84)
Creativity Awards (9)
Cure Sickle Cell Initiative Clinical Trial Stage Projects (3)
Diagnostic Translational Research Projects (3)
Discovery Research Projects (12)
Discovery Research Projects (1)
Disease Team Planning (22)
Disease Team Research I (15)
Disease Team Therapy Development – Research (12)
Disease Team Therapy Development III (6)
Disease Team Therapy Planning I (19)
Early Translational from Disease Team Conversion (3)
Early Translational I (16)
Early Translational II (24)
Early Translational III (21)
Early Translational IV (14)
Foundation – Discovery Stage Research Projects (39)
Genomics Centers of Excellence Awards (R) (3)
hiPSC Derivation (1)
hPSC Repository (1)
Inception – Discovery Stage Research Projects (39)
iPSC Consortia Award (1)
Late Stage Preclinical Projects (49)
Major Facilities (12)
Manufacturing Network Grant (9)
Medical Device Translational Research Projects (1)
New Cell Lines (18)
New Faculty I (26)
New Faculty II (24)
New Faculty Physician Scientist (15)
Patent Assistance Fund Awards (8)
Preclinical Development Awards (7)
Progression Award – Discovery Stage Research Projects (8)
Quest – Discovery Stage Research Projects (144)
ReMIND – Discovery Stage ReMIND (5)
Research Leadership (14)
Research Training Grant (18)
Research Training II (17)
SEED Grant (74)
Shared Labs (34)
SPARK (18)
Strategic Partnership I (2)
Strategic Partnership II (1)
Strategic Partnership III Track A (2)
Targeted Clinical Development (1)
Therapeutic Translational Research Projects (81)
Therapeutic Translational Research Projects (1)
Tissue Collection for Disease Modeling (7)
Tool Translational Research Projects (7)
Tools and Technologies I (23)
Tools and Technologies II (20)
Tools and Technologies III (22)
Training Grant I-1 (8)
Training Grant I-2 (5)
Training Grant I-3 (3)
Translating Center (1)
Transplantation Immunology (20)
Human Stem Cell Use
(All)
Adult or Tissue Stem Cell (318)
Cancer Stem Cell (46)
Directly Reprogrammed Cell (11)
Embryonic Stem Cell (389)
iPS Cell (303)
N/A (405)
Other (11)
SCNT (2)
Somatic Cell (30)
Vital Research Opportunity (3)
Cell Line Generation
(All)
Adult or Tissue Stem Cell (61)
Cancer Stem Cell (12)
Directly Reprogrammed Cell (2)
Embryonic Stem Cell (52)
iPS Cell (133)
N/A (1048)
Other (9)
SCNT (2)
Collaborative Funder
(All)
Andalusia, Spain (1)
Australia (3)
Canada (2)
France (1)
Germany (10)
Japan (1)
NIH (3)
United Kingdom (3)
Victoria, Australia (6)
Award Status
(All)
Active (348)
Closed (1115)
Pre-Active (18)
Institution
Researcher name
Grant Type
Grant Title
Award Value
Parkinson’s Institute
R. Jeremy Nichols
Basic Biology III
Understanding the role of LRRK2 in iPSC cell models of Parkinson’s Disease
$1,482,822
Scripps Research Institute
Dr. Kristin K Baldwin Dr.
Basic Biology III
Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing
$1,705,500
University of California, Berkeley
Dr. Michael P. Rapé Dr.
Basic Biology III
Ubiquitin-dependent control of hESC self-renewal and expansion
$1,224,805
University of California, Los Angeles
Dr. Gay Miriam Crooks
Basic Biology III
Forming the Hematopoietic Niche from Human Pluripotent Stem Cells
$1,252,857
University of California, San Diego
Dr. Charles C. King Dr.
Basic Biology III
Biological relevance of microRNAs in hESC differentiation to endocrine pancreas
$1,313,649
University of California, Berkeley
Dr. Song Li
Basic Biology III
Induced Pluripotent Stem Cells for Tissue Regeneration
$1,209,148
University of California, San Diego
Karl H. Willert
Tools and Technologies II
Homologous recombination in human pluripotent stem cells using adeno-associated virus.
$1,659,043
Stanford University
Dr. Marius Wernig MD, PhD
Tools and Technologies II
Cellular tools to study brain diseases affecting synaptic transmission
$1,664,382
Stanford University
Professor Irving L Weissman MD
Tools and Technologies II
Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs
$1,463,814
TriFoil Imaging, Inc.
Dr. Joann Zhang
Tools and Technologies II
Tri-resolution Visualization System for Stem Cells and Tissue Regeneration Monitoring
$1,456,989
Cedars-Sinai Medical Center
Professor Clive Niels Svendsen
Tools and Technologies II
Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy.
$1,933,022
University of California, Berkeley
Dr. David V. Schaffer
Tools and Technologies II
Engineering Defined and Scaleable Systems for Dopaminergic Neuron Differentiation of hPSCs
$1,340,816
Stanford University
Dr. Brian K. Rutt
Tools and Technologies II
Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters
$1,833,348
Parkinson’s Institute
Dr. Birgitt Schuele
Tools and Technologies II
Editing of Parkinson’s disease mutation in patient-derived iPSCs by zinc-finger nucleases
$1,327,983
University of California, San Francisco
Dr Daniel A. Lim MD, PHD
Tools and Technologies II
Development and preclinical testing of new devices for cell transplantation to the brain.
$1,795,891
GMR Epigenetics
Dr. Jifan Hu
Tools and Technologies II
Robust generation of induced pluripotent stem cells by a potent set of engineered factors
$1,356,052
Stanford University
Dr. Sarah C Heilshorn
Tools and Technologies II
Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels
$600,695
University of California, San Diego
Dr. Lawrence S. B. Goldstein
Tools and Technologies II
Developing a method for rapid identification of high-quality disease specific hIPSC lines
$1,686,069
University of California, Los Angeles
Dr. Richard A. Gatti
Tools and Technologies II
Use of hiPSCs to develop lead compounds for the treatment of genetic diseases
$1,833,054
Stanford University
Dr. Theo D. Palmer PhD
Tools and Technologies II
Development of small molecule screens for autism using patient-derived iPS cells
$1,797,606
University of California, Berkeley
Dr. Steven M. Conolly
Tools and Technologies II
Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo
$1,311,596
University of California, San Diego
Shu Chien
Tools and Technologies II
Development of Synthetic Microenvironments for Stem Cell Growth and Differentiation
$1,706,628
University of California, Los Angeles
Dr. Thomas Carmichael M.D., Ph.D.
Tools and Technologies II
Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke
$1,825,613
Stanford University
Dr. Michele Calos
Tools and Technologies II
Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation
$1,592,897
Fluidigm Corporation
Dr. Marc A Unger
Tools and Technologies II
Development and Application of Versatile, Automated, Microfluidic Cell Culture System
$1,939,236
University of California, Los Angeles
Dr. Martin Gabriel Martin
Tools and Technologies II
Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders
$1,783,250
University of California, Los Angeles
Dr. Sophie X Deng
Early Translational II
Regeneration of Functional Human Corneal Epithelial Progenitor Cells
$697,507
University of California, San Francisco
Dr. Arturo Alvarez-Buylla
Early Translational II
Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy
$1,564,016
University of California, Davis
Dr. Mark Zern
Early Translational II
Liver Cell Transplantation
$4,212,621
Stanford University
Dr. Michele Calos
Early Translational II
Stem Cell Therapy for Duchenne Muscular Dystrophy
$2,267,261
University of California, Irvine
Dr. Brian J. Cummings
Early Translational II
Neural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury
$1,517,767
University of California, Los Angeles
Dr. Sophie X Deng
Early Translational II
Regeneration of Functional Human Corneal Epithelial Progenitor Cells
$1,524,947
Cedars-Sinai Medical Center
Dr. Dan Gazit
Early Translational II
Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures
$1,927,698
University of California, Los Angeles
Leif Havton
Early Translational II
Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons
$75,628
University of California, Irvine
Leif A Havton
Early Translational II
Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons
$1,527,011
City of Hope, Beckman Research Institute
Dr. Yanhong Shi Ph.D.
Early Translational II
Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell
$1,835,983
City of Hope, Beckman Research Institute
Dr. David Louis DiGiusto
Early Translational II
Development of RNA-based approaches to stem cell gene therapy for HIV
$3,097,160
University of California, Davis
Dr. Roslyn Rivkah Isseroff
Early Translational II
Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds
$4,629,747
University of California, Los Angeles
Dr. Noriyuki Kasahara
Early Translational II
Stem cell-based carriers for RCR vector delivery to glioblastoma
$3,340,625
Salk Institute for Biological Studies
Dr. Fred H Gage
Early Translational II
Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model
$2,472,839
University of California, Irvine
Dr. Henry John Klassen
Early Translational II
Human retinal progenitor cells as candidate therapy for retinitis pigmentosa
$1,803,768
Children’s Hospital of Los Angeles
Dr. Markus Muschen
Early Translational II
Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication
$850,769
University of California, San Francisco
Markus Muschen
Early Translational II
Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication
$2,756,536
Buck Institute for Age Research
Dr. Xianmin Zeng
Early Translational II
Banking transplant ready dopaminergic neurons using a scalable process
$4,983,013
iPierian, Inc.
Dr. John Dimos
Early Translational II
New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells
$2,410,000
University of California, Los Angeles
Prof. Bruno Peault
Early Translational II
Harnessing native fat-residing stem cells for bone regeneration
$5,359,076
Scripps Research Institute
Peter G. Schultz
Early Translational II
Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis
$6,047,249
University of California, San Diego
Professor Alysson R Muotri
Early Translational II
Developing a drug-screening system for Autism Spectrum Disorders using human neurons
$1,376,198
University of California, Irvine
Dr. Leslie M Thompson
Early Translational II
A hESc-based Development Candidate for Huntington’s Disease
$3,955,038
University of California, San Diego
Catriona Jamieson
Early Translational II
Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy
$3,103,041
« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
…
30
Next »